Dynavax Technologies (DVAX) Well Positioned With Medigen Collaboration on COVID-19 Vaccine Programs - Cowen
Tweet Send to a Friend
Cowen analyst Phil Nadeau reiterated an Outperform rating and $20.00 price target on Dynavax Technologies (NASDAQ: DVAX) citing a major ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
